|
Information about Alzheimer's at memantine.com Memantine.com | Alzheimer's: Here you get information about forms of diseases, drugs, therapies, care and latest research results.
Namenda (Memantine), Alzheimer's medication Namenda (Memantine)is a medication used in the treatment of Alzheimer's. ... Namenda (memantine hydrochloride) is medication used in treatment of Alzheimer's Disease. ...
Information about Alzheimer's Care at memantine.com Memantine.com | Alzheimer's Care: Here you get information about forms of diseases, drugs, therapies, care and latest research results.
Memantine - Wikipedia, the free encyclopedia Memantine is the first in a novel class of Alzheimer's disease medications ... Memantine: a review of its use in Alzheimer's disease" ...
memantine (Namenda) - drug class, medical uses, medication side effects ... Specifies the medication memantine (Namenda), a drug used for the treatment of moderate to severe dementia of the Alzheimer's type.
Memantine And Alzheimer's Disease Alzheimer's disease news update ... Memantine And Alzheimer's Disease ... In the present study, researchers report that memantine has a much more complex ...
MEMANTINE - ORAL (Namenda) side effects, medical uses, and drug ... Read more about the prescription drug MEMANTINE - ORAL. ... Newer Drugs May Up Weight in Alzheimer's Patients. Brain Cells Give New Clues to Alzheimer's ...
FDA Approves Alzheimer's Drug The entry page to Global Action on Aging's Web site. ... behavior problems in Alzheimer's patients showed that patients who got Memantine ...
Alzheimer's: New Drug Helps Slow Memory Loss - Watch WebMD Video About 4 million Americans have alzheimer's, with 360,000 new cases reported each ... Now the latest treatment for the memory-robbing disease offers new hope for ...
Memantine - Yahoo! Health Before using memantine, tell your doctor if you are allergic to any drugs, or if ... Memantine is used to treat moderate to severe dementia of the Alzheimer's type. ...
|
|
|
Memantine in alzheimer's |
Alzheimer's Drug Approved (Memantine) - Alzheimer's Disease Information on MedicineNet.comThe FDA has approved a new drug, Namenda (memantine), to
treat Alzheimer's disease. Memantine helps treat the symptoms of Alzheimer's disease although
there is no evidence that it modifies the underlying pathology of the disease.
While the benefits of taking memantine appear to be modest, Namenda is the first
drug approved to treat the moderate to severe Alzheimer's disease.The first two double-blind studies, each of about six months duration, were
conducted in the United States, and involved about 250 and about 400 patients,
respectively. The larger study was carried out in patients already taking
donepezil, a drug already approved for the treatment of Alzheimer's Disease.
Both studies showed that patients on memantine experienced less deterioration in
their symptoms compared to patients treated with placebo during the study.
|
Rating: 3.5 из 5 (голосов: 151) |
13 june 2008
Николай Каретный
|
|
|
memantine online
memantine brand
memantine dose
memantine use
|
|
|
Alzheimer's Drug Considered as Fibromyalgia Treatment
About - News & Issues - Apr 20, 2009
NEWSBRIEF: Some researchers believe the Alzheimer's disease drug Namenda (memantine) may help reduce gray-matter atrophy associated with fibromyalgia. ...
CATIE-AD: Atypical Antipsychotics Linked to Weight Gain in Older Women
Medscape - Apr 23, 2009
At randomization, 46% were using antihypertensive agents, 60% were taking a cholinesterase inhibitor or memantine, 24% were on cholesterol-lowering ...
Big Idea, Small Detail: Health, Money and Work
Reader's Digest - Apr 14, 2009
According to the Wall Street Journal, a drug cocktail of memantine plus older drugs may be key in slowing the effects of Alzheimer's. ...
Non-drug Treatment Of Alzheimer's Disease? Long-term Benefit Not ...
Science Daily (press release) - Apr 15, 2009
None of the 33 studies compared a non-drug intervention with a drug intervention assessed by IQWiG (cholinesterase inhibitors, ginkgo compounds, memantine). ...
Forest Laboratories, Inc Q1 2009 Earnings Call Transcript
Seeking Alpha - Apr 21, 2009
The NDA for memantine ER is completed and waiting in the wings as we continue to monitor the patent litigation activities around Namenda. ...
FRX
|
|
|
|